Novozymes A/S (ETR:NZM2)

Market Cap	28.09B +7.4%
Revenue (ttm)	4.30B +4.9%
Net Income	631.60M +11.8%
EPS	1.35 -32.0%
Shares Out	n/a
PE Ratio	44.47
Forward PE	26.55
Dividend	0.88 (1.48%)
Ex-Dividend Date	Aug 25, 2026

Volume	1,128
Open	60.28
Previous Close	60.50
Day's Range	59.60 - 60.28
52-Week Range	46.74 - 60.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Novozymes

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; e...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 11,263
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NZM2

Financial Performance

In 2025, Novozymes's revenue was 4.16 billion, an increase of 8.45% compared to the previous year's 3.83 billion. Earnings were 583.60 million, an increase of 90.84%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error